CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of bacteriophage therapy to enhance the effectiveness of antibiotics against multidrug-resistant Enterococcus faecium. It aims to identify which antibiotics work best with phages, understand the bacteria's survival mechanisms, and explore how host factors influence treatment outcomes.
Due to its multidrug resistance (MDR), Enterococcus faecium (Efm) poses a challenge to the healthcare system and renders most standard antibiotics useless.
Bacteriophage (phage) therapy has resurfaced as a treatment strategy for bacterial infections due to increasing antibiotic resistance.
Its advantages include specificity, low side effects and production costs, especially when used in combination with standard-of-care antibiotics.
Phage therapy has been successful in compassionate use, but its…
UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Boulder Co
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
